Mesenchymal stem cells adopt β-cell fate upon diabetic pancreatic microenvironment

Pancreas

Volumn 38, Issue 3, 2009, Pages 275-281

  Chang, Caihong ^a,b   Wang, Xinjun ^a,b   Niu, Deliang ^c   Zhang, Zhan ^b   Zhao, Hongyang ^d   Gong, Feili ^a,e  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e NONE   (China)

Author keywords

Experimental diabetes; Mesenchymal stem cells; Microdissection; Microenvironment; Transplantation

Indexed keywords

EOSIN; GLUCOSE; HEMATOXYLIN; INSULIN; MESSENGER RNA; TRANSCRIPTION FACTOR PDX 1; HOMEODOMAIN PROTEIN; INSULIN PROMOTER FACTOR 1; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FATE; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; IMMUNOREACTIVITY; LASER CAPTURE MICRODISSECTION; LYMPHOCYTE; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SRY GENE; STAINING; ANIMAL; BLOOD; BODY WEIGHT; CELL DIFFERENTIATION; CYTOLOGY; DISEASE MODEL; EXPERIMENTAL DIABETES MELLITUS; GENETICS; GRAFT SURVIVAL; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; MICRODISSECTION; MINIPIG; PHYSIOLOGY; SWINE;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CELL DIFFERENTIATION; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; FEMALE; GENES, SRY; GRAFT SURVIVAL; HOMEODOMAIN PROTEINS; INSULIN; INSULIN-SECRETING CELLS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICRODISSECTION; RNA, MESSENGER; SWINE; SWINE, MINIATURE; TRANS-ACTIVATORS;

EID: 65549099601     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e318191521c     Document Type: Article

References (30)

1. Oh SH, Muzzonigro TM, Bae SH, et al. Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes. Lab Invest. 2004;84:607-617.
2. Choi KS, Shin JS, Lee JJ, et al. In vitro trans-differentiation of rat mesenchymal cells into insulin-producing cells by rat pancreatic extract. Biochem Biophys Res Commun. 2005;330:1299-1305.
3. Wolfe-Coote S, Louw J, Woodroof C, et al. Development, differentiation, and regeneration potential of the Vervet monkey endocrine pancreas. Microsc Res Tech. 1998;43:322-331.
4. Rosenberg L, Brown RA, Duguid WP. A new approach to the induction of duct epithelial hyperplasia and nesidioblastosis by cellophane wrapping of the hamster pancreas. J Surg Res. 1983;35:63-72.
5. Chen LB, Jiang XB, Yang L, et al. Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. World J Gastroenterol. 2004;10:301-320.
6. Tang DQ, Cao LZ, Burk Hardt BR, et al. In vivo and vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes. 2004;53:1721-1732.
7. Taneera J, Rosengren A, Renstrom E. Failure of transplanted bone marrow cells to adopt a pancreatic α-cell fate. Diabetes. 2006;55:290-296.
8. Ianus A, Holz GG, Theise ND, et al. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest. 2003;111:843-850.
9. Lechner A, Yang Y-G, Blacken RA. No evidence for significant transdifferentiation of bone marrow into pancreatic β-cells in vivo. Diabetes. 2004;53:616-623.
10. Choi JB, Uchino H, Azuma K, et al. Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells. Diabetes. 2003;46:1366-1374.
11. Moriscot C, de Fraipont F, Richard M-J, et al. Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro. Stem Cells. 2005;23:594-613.
12. Li L, Xie T. Stem cell niche structure and function. Annu Rev Cell Dev Biol. 2005;21:605-616.
13. Wilson A, Trumpp A. Bone marrow haematopoietic stem cell niches. Nature. 2006;6:93-105.
14. Gregory CA, Ylostalo J, Prockop DJ. Adult bone marrow stem/ progenitor cells (MSCs) are preconditioned by microenvironmental Bniches[ in culture: a two-stage hypothesis for regulation of MSC fate. Sci. STKE. 2005;294:37.
15. Chang C, Niu D, Zhou H, et al. Mesenchymal stem cells contribute to insulin-producing cells upon microenvironmental manipulation in vitro. Transplant Proc. 2007;39:3363-3368.
16. Ahn YB, Xu G, Marselli L, et al. Changes in gene expression in beta cells after islet isolation and transplantation using laser-capture microdissection. Diabetologia. 2007;50:334-342.
17. Dufrane D, van Steenberge M, Guio Y, et al. Streptozotocin-induced diabetes in large animals (pigs/primates): role of GLUT2 transporter and beta-cell plasticity. Transplantation. 2006;81:36-45.
18. Larsen MO, Wilken M, Gotfredsen CF, et al. Mild streptozotocin diabetes in the Göttingen minipig. A novel model of moderate insulin deficiency and diabetes. Am J Physiol Endocrinol Metab. 2002;282:E1342-E1351.
19. Banerjeea M, Kumarb A, Bhonde RR. Reversal of experimental diabetes by multiple bone marrow transplantation. Biochem Biophys Res Commun. 2005;328:318-325.
20. Sumi S, Gu Y, Hiura A. Stem cells and regenerative medicine for diabetes mellitus. Pancreas. 2004;29:85-89.
21. Lee RH, Seo MJ, Reger RL. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci U S A. 2006;103:17438-17443.
22. Roloff TC, Nuber UA. Chromatin. Epigenetics and stem cells. Eur J Cell Biol. 2005;84:123-135.
23. DiGirolamo CM, Stokes D, Colter D, et al. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol. 1999;107:275-281.
24. Tremain N, Korkko J, Ibberson D, et al. MicroSAGE analysis of 2353 expressed genes in a single cell-derived colony of undifferentiated human mesenchymal stem cells reveals mRNAs of multiple cell lineages. Stem Cells. 2001;19:408-418.
25. Li JY, Meng LJ, Zhu Y. Immunosuppressive property of mesenchymal stem cells (MSCs) in mixed lymphocyte reactions in vitro. Blood. 2005;106:4313Y4325.
26. Zhang W, Ge W, Li C, et al. Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells. 2004;13:263-271.
27. Zhao RC, Liao L, Han Q. Mechanisms of and perspectives on the mesenchymal stem cell in immunotherapy. J Lab Clin Med. 2004;143:284-291.
28. Beyth S, Borovsky Z, Mevorach D, et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood. 2005;105:2214-2219.
29. Uccelli A, Moretta L, Pistoia V. Immunoregulatory function of mesenchymal stem cells. Eur J Immunol. 2006;36:2566-2573.
30. Itakura S, Asari S, Rawson J, et al. Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat. Am J Transplant. 2007;7: 336-346.